Pliant Therapeutics, founded in South San Francisco, California, is a biopharmaceutical company dedicated to discovering and developing novel therapies for fibrotic diseases. The company's core mission is to bring hope to patients suffering from fibrosis by targeting the molecular drivers of these diseases. Pliant Therapeutics focuses on creating breakthrough integrin therapies that are potentially safer and more effective for patients.
Notable affiliated individuals include a highly experienced team of experts in fibrosis and drug development. The company has attracted significant investment from leading venture capital firms and has made key advancements in its therapeutic pipeline. Pliant Therapeutics has had a substantial impact on the biopharmaceutical industry by advancing the understanding and treatment of fibrotic diseases, offering new hope to patients worldwide.
